C4 Therapeutics Shares Are Trading Lower. The Company Announced the Abstract Sharing Clinical Data From Its Ongoing Phase 1 Clinical Trial of CFT1946 in Mutant BRAF V600 Solid Tumors, Was Released in Conjunction With the ESMO Congress 2024.
C4 Therapeutics Shares Are Trading Lower. The Company Announced the Abstract Sharing Clinical Data From Its Ongoing Phase 1 Clinical Trial of CFT1946 in Mutant BRAF V600 Solid Tumors, Was Released in Conjunction With the ESMO Congress 2024.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.